Reports for TEVA CANADA LIMITED

Formerly known as ACTAVIS PHARMA COMPANY

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

103 (48%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PROPRANOLOL 40MG TABLET Resolved 2020-04-10 2020-05-21 111835
TEVA-PROPRANOLOL 40MG TABLET Resolved 2022-09-07 2023-01-12 168741
TEVA-PROPRANOLOL 80MG TABLET Resolved 2023-06-20 2023-07-05 195760
TEVA-PROPRANOLOL 20MG TABLET Resolved 2025-03-27 2025-04-24 253565
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1778
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-05-02 2025-05-02 256462
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-21 113761
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-12-17 2021-01-21 130291
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-18 199554
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-04-10 250906
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-05-02 2025-05-08 256465
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-12 2019-10-04 93656
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-02-06 2025-05-08 249731
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-07-05 195118
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-25 2021-04-21 136341
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-03-06 2020-05-21 107986
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-06-04 111826
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-05-29 111823
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2025-04-02 2025-04-10 253963
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-07-12 194163
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-04-29 2025-04-29 256079
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-TENOFOVIR 300MG TABLET Discontinued 2025-04-29 2025-04-29 256088
TEVA-TOPISONE 0.05% LOTION Discontinued 2024-06-28 2024-06-29 231589
TEVA-TOPOTECAN 4MG POWDER FOR SOLUTION Discontinued 2025-04-29 2025-04-29 256104
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-TRIAMTERENE/HCTZ 25MG 50MG TABLET Discontinued 2017-06-27 2017-06-27 14060
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091

Showing 261 to 280 of 300